Hospira Recalls Overfilled Injection

Hospira Recalls Overfilled InjectionAs per reports, it has been revealed that Hospira Inc. (HSP) has recalled one lot of Hydromorphone Hydrochloride Injection, as it contained more than desired opioid. The recall has been made after considering the FDA.

The FDA said that the affected lot number of the injection solution is 07547LL and bears expiry date of July 1, 2013. The regulatory officials further revealed that the opioid pain medications can risk life, if it is taken in large amount. Some of the problems that can be caused due to it are respiratory depression, low blood pressure and heart sink and circulatory collapse.

It has been further revealed that the affected lot was distributed to different wholesalers and hospitals in many places. Some of the many places were New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Washington, and Wisconsin and Indiana, Louisiana, Maryland, Massachusetts, Minnesota, Missouri, Mississippi and Alaska, Alabama, Arizona, California, Colorado, Connecticut.

Till now, there are no reports of any incident that has been caused due to over dose of the drug. "While voluntary recalls aren't necessarily emblematic of major (manufacturing) problems, we are concerned by the fact that both of the recent recalls involved overfilling opioid products", said analyst Leerink Swann.